LIP
XFOR icon

Lighthouse Investment Partners’s X4 Pharmaceuticals XFOR Stock Holding History

Lighthouse Investment Partners’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,200
Closed -$88.8K – 1105
2025
Q4 		$88.8K Buy
+22,200
New +$80.7K ﹤0.01% 811
2024
Q2 		– Sell
-2,347
Closed -$97.9K – 558
2024
Q1 		$97.9K Buy
+2,347
New +$65.3K ﹤0.01% 367

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Lighthouse Investment Partners's XFOR Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of X4 Pharmaceuticals (XFOR) in Q1 2026, closing a stake of 22,200 shares — an estimated $88.8K sold.

Lighthouse Investment Partners first reported a position in XFOR in Q1 2024 and held it in 2 quarters. The position peaked at $97.9K in Q1 2024. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining X4 Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 22,200 X4 Pharmaceuticals shares in Q1 2026, an estimated $88.8K.
  • Lighthouse Investment Partners first reported a position in X4 Pharmaceuticals in Q1 2024 and held it in 2 quarters.
  • Lighthouse Investment Partners's X4 Pharmaceuticals position peaked at $97.9K in Q1 2024.
  • 84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.